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Summary
Aging leads to hypothalamic inflammation, but does so more
slowly in mice whose lifespan has been extended by mutations
that affect GH/IGF-1 signals. Early-life exposure to GH by
injection, or to nutrient restriction in the first 3 weeks of life,
also modulate both lifespan and the pace of hypothalamic
inflammation. Three drugs extend lifespan of UM-HET3 mice in
a sex-specific way: acarbose (ACA), 17-a-estradiol (17aE2), and
nordihydroguaiaretic acid (NDGA), with more dramatic longevity
increases in males in each case. In this study, we examined the
effect of these anti-aging drugs on neuro-inflammation in
hypothalamus and hippocampus. We found that age-associated
hypothalamic inflammation is reduced in males but not in
females at 12 months of age by ACA and 17aE2 and at 22 months
of age in NDGA-treated mice. The three drugs blocked indices of
hypothalamic reactive gliosis associated with aging, such as Iba-
1-positive microglia and GFAP-positive astrocytes, as well as age-
associated overproduction of TNF-a. This effect was not observed
in drug-treated female mice or in the hippocampus of the drug-
treated animals. On the other hand, caloric restriction (CR; an
intervention that extends the lifespan in both sexes) significantly
reduced hypothalamic microglia and TNF-a in both sexes at
12 months of age. Together, these results suggest that the extent
of drug-induced changes in hypothalamic inflammatory pro-
cesses is sexually dimorphic in a pattern that parallels the effects
of these agents on mouse longevity and that mimics the changes
seen, in both sexes, of long-lived nutrient restricted or mutant
mice.
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Introduction
Increased inflammatory activity accompanies normal brain aging. Aging
retardation can be achieved in mice by inhibiting activation of hypotha-
lamic nuclear factor-kB (NF-kB) inflammatory pathways (Zhang et al.,
2013). Similarly, limiting nutrient availability in the first 3 weeks of life
(the crowded litter (CL) model) leads to reduced hypothalamic gliosis in
parallel with reduced activation of tumor necrosis factor (TNF-a) in the
aged CL mice (Sadagurski et al., 2015a). Furthermore, the mutations
that interfere with GH production or response, in the long-lived Snell
dwarf, Ames dwarf or growth hormone receptor deficient (GHRKO)
mice lead to reduced age-associated hypothalamic inflammation in old
mice (Sadagurski et al., 2015b). Recent studies by the NIA Interventions
Testing Program (ITP) demonstrated that lifespan can also be increased in
male UM-HET3 mice exposed to three drugs: acarbose (ACA), nordihy-
droguaiaretic acid (NDGA), and 17-a-estradiol (17aE2; Harrison et al.,
2013). The genetically heterogeneous UM-HET3 mice are the ideal
model system to study lifespan, because the tested populations are
reproducible and represent great genetic diversity (Miller et al., 1999,
2011). NDGA and 17aE2 do not extend lifespan of female UM-HET3
mice, and the effect of ACA, although statistically significant in both
sexes, is dramatically larger in males than in females (Harrison et al.,
2013). Neither the site(s) of action responsible for these longevity effects,
nor the basis for the sex specificity, are known.
It is well documented that many aspects of carbohydrate and energy
metabolism, including pancreatic function and insulin action on the liver
and other target organs, are influenced by the hypothalamus via
neuronal signals (Myers, 2006) and that obesity, insulin resistance and
metabolic syndrome are associated with hypothalamic inflammation
(Morton et al., 2006; Thaler et al., 2012). Glial cells are particularly
sensitive to homeostatic imbalances, and increased glial activity is a well-
established sign of an inflammatory response (Arvin et al., 1996).
Activation of NF-kB dependent cytokine production and hypothalamic
glial activity increases with age, and augmentation of this effect can
shorten mouse lifespan (Zhang et al., 2013), while blunting hypothala-
mic inflammatory signals can increase lifespan in mice (Zhang et al.,
2013). Glial activity and production of mRNA for the inflammatory
cytokine TNF-a are diminished in long-lived, GH-deficient Ames and Snell
dwarf mice, and in GHRKO mice (Sadagurski et al., 2015b), but not in
mice with liver-specific disruption of GHR, a mutant that does not show
increased longevity (List et al., 2014).These observations are all consis-
tent with the idea that lower hypothalamic inflammation may modulate
aging processes, and lifespan, in mice.
Increased neuro-inflammatory reaction is frequently observed not
only in hypothalamus, but also in the hippocampus during normal brain
aging (Gavilan et al., 2007). Age-related hippocampal inflammatory
processes are potentially related to hippocampal neurodegeneration
(Mattson & Magnus, 2006). The aging hippocampus does not appear to
suffer a generalized loss of cells, although atrophy of the structure may
occur in humans, and these changes are thought to be an important
contributor to age-related cognitive impairments (Miller & O’Callaghan,
2005). Activated microglial cells are observed in the hippocampus of
aged animals (Lynch et al., 2010), and high levels of several cytokines
such as IL-1b and TNF-a, produced by the activated microglia, are
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significantly increased in hippocampus of aged mice and rats (Ye &
Johnson, 1999; Norden & Godbout, 2013).
ACA is an inhibitor of intestinal a-glucosidase (Balfour & McTavish,
1993). It inhibits digestion of polysaccharides and delays the uptake of
sugars from the GI tract. It lowers postprandial glucose excursions and is
used clinically for the treatment of type 2 diabetes (DiNicolantonio et al.,
2015). In UM-HET3 mice, ACA treatment beginning at 4 months of age
increased median and maximal lifespan in males much more strongly
than in females (Harrison et al., 2013). When started at 16 months, ACA
significantly increased median longevity in males and 90th percentile
lifespan in both sexes (Strong et al., 2016). ACA reduced fasting insulin
significantly in young males but not in females, while the reduction in
body weight and age-associated decline in voluntary activity was more
dramatic in ACA-fed females than in males (Harrison et al., 2013).
17aE2 is an optical isomer of 17-b-estradiol that has reduced affinity
for estrogen receptors (Zhurova et al., 2009). This form of estrogen is
reported to be neuroprotective in vitro in cultured cells and in vivo in an
ischemia–reperfusion animal model (Perez et al., 2005). It also has been
reported to protect against neurodegeneration in cell and animal models
of Parkinson’s disease (Dykens et al., 2005) and cerebrovascular disease
(Liu et al., 2005). An initial report using 17aE2 at 4.8 ppm showed
increased median and maximal lifespan in males but no effects on
lifespan in female mice (Harrison et al., 2013). A second study using
17aE2 at 14.4 ppm robustly extended both median and maximal
lifespan in males, but showed no effect in females, and 17aE2-treated
males lived significantly longer than either control or treated females
(Strong et al., 2016).
NDGA is both a lipoxygenase inhibitor and potent antioxidant (Lu
et al., 2010). Two ITP studies have shown that NDGA increases median
lifespan, but only in male mice (Strong et al., 2008; Harrison et al.,
2013). The lack of effect of NDGA on female lifespan cannot be
explained by effects on body weight (Miller et al., 2007; Harrison et al.,
2013) or by differences in blood NDGA concentrations. NDGA inhibits
inflammatory responses that are thought to play a role in many age-
related diseases (Ferrandiz & Alcaraz, 1991).
Changes in gene expression and glial localization in the course of
normal brain aging are sexually dimorphic (Berchtold et al., 2008). For
example, males have more microglia early in postnatal development,
whereas females have more microglia with an activated morphology
later in life, as young adults (Schwarz et al., 2012). Furthermore, the
numbers and diversity of astrocytes are also sexually differentiated across
brain regions (McCarthy & Arnold, 2011). Gene expression of a large
number of cytokines in the aging brain is highly dependent upon sex and
region (Bilbo et al., 2012). These collective data suggest that regional-,
sex-, and age-dependent differences in glia cells and their inflammatory
capacity could play a role in the sex-specific lifespan benefit of ACA,
17aE2, and NDGA.
In this study, we evaluated the effect of ACA, 17aE2, and NDGA on
age-associated inflammatory responses in two brain areas that are
sensitive to aging and age-related neurological changes (hypothalamus
and hippocampus), to determine whether these are modified by the anti-
aging drugs and whether the effects of the drugs on inflammation differ
in males and females.
Results
Effect of ACA and 17aE2 on CNS inflammation in aged mice
We evaluated two indices of inflammatory responses, that is, glial
fibrillary acidic protein (GFAP, a marker of astrocyte activation), and
production of TNF-a by microglia, in the hypothalamus and hippocam-
pus of 12-month-old UM-HET3 male and UM-HET3 female mice that
had been exposed to ACA or 17aE2 from 4 months of age.
We used Iba-1 as a marker of microglial number and analyzed results
by analysis of variance to test the main effects of sex and drug exposure
and the [sex 9 drug] interaction term. ACA had a significant effect
(P = 0.01) reducing activated microglia in both hypothalamus and
hippocampus, with no significant main effect of sex (P = 0.07 for MBH
and P = 0.7 for hippocampus; Figs 1 and 2A,B). The interaction term
was significant at P = 0.035 for hypothalamus, showing that the drug
had greater effects on microglial numbers in males than in females
(Fig. 1B). There was no evidence for sex specificity (P = 0.33) in
hippocampus (Fig. 2A,B).
Previous studies by us and others have demonstrated that about 80%
of the hypothalamic Iba1+ cells produced tumor necrosis factor-a (TNF-
a), indicating that they are inflammatory (Zhang et al., 2013; Sadagurski
et al., 2015a). Analysis of variance revealed a significant effect of drug
(P = 0.008) and a significant interaction of sex and drug on TNF-a
expression in the MBH (P = 0.003), without a main effect of sex
(P = 0.29; Fig. 1). Thus, ACA diminishes this aspect of inflammation
more dramatically in male than in female mice, with effects demonstra-
ble as early as 12 months of age. We were not able to reliably detect
TNF-a by immunostaining in the hippocampus.
17aE2 treatment had effects similar to those of ACA on hypotha-
lamic microglia (Fig. 1). In male mice evaluated at 12 months of age,
17aE2 diminished hypothalamic microglia (P = 0.02), with significant
interaction terms (P = 0.02). In addition, the ANOVA revealed a
significant effect of 17aE2 (P = 0.001) and a significant interaction of
sex and drug (P = 0.0015) on TNF-a expression in the MBH of 12-
month-old 17aE2-treated animals (Fig. 1). For none of these assays was
there a significant main effect of sex per se (Fig. 1). A parallel analysis of
the hippocampus showed no effect of 17aE2 (P = 0.83) and no
interaction between 17aE2 and sex (P = 0.13; Fig. 2A,B). Astrogliosis
with advancing age is correlated with increased expression of (GFAP;
Nichols et al., 1995). The number of GFAP-positive astrocytes in
hypothalamus was higher in male control than in female control
(P = 0.03) and was diminished by both ACA (P < 0.0001) and 17aE2
(P = 0.001), with significantly more effect in male than in female mice
(interaction P = 0.044 for ACA and P = 0.039 for 17aE2; Fig. 3A,B).The
number of GFAP-positive astrocytes in the hippocampus depended on
sex at 12 months of age (P = 0.009, with males demonstrating higher
GFAP-positive cell at this age), but there was no significant effect of
ACA (P = 0.42) or 17aE2 (P = 0.83) and no significant interaction term
in the hippocampus (for ACA, P = 0.48 and for 17aE2, P = 0.13;
Fig. 4A,B).
We detected no significant effects of sex or treatment in the total
number of cells detected by DAPI staining (data not shown).
In support of these findings, two-way ANOVA revealed a
significant effect of caloric restriction (an intervention that extends
the lifespan in both sexes) on both hypothalamic microglia
(P = 0.0001) and TNF-a (P = 0.0001) without significant interaction
of sex and drug for both endpoints at 12 months of age (Fig. S1A,B,
Supporting information). The effect of CR on GFAP-positive astro-
cytes in the hypothalamus did not reach statistical significance
(P = 0.09; Fig. S1C,D, Supporting information). Consistent with the
hippocampal results for 12-month-old ACA and 17aE2-treated mice,
the number of GFAP-positive astrocytes in the hippocampus
depended on sex (P = 0.002), but there were no significant effects
of CR on microglia (P = 0.35) or number of astrocytes (P = 0.07;
Fig. S1E–H, Supporting information).
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Effect of NDGA on CNS inflammation in old mice
The anti-inflammatory agent NDGA leads to a male-specific extension of
median lifespan. The effects of NDGA are dose dependent but without
an effect on maximal lifespan in either sex (Harrison et al., 2013; Strong
et al., 2016). Our previous work has shown continuing age-related
increase in levels of hypothalamic inflammatory markers (TNF-a, Iba-1,
and GFAP) between 12 and 22 months in UM-HET3 mice (Sadagurski
et al., 2015a). At 22 months of age, we found reduced numbers of
GFAP-immunostained astrocytes and Iba-1 microglia in the MBH of
NDGA-treated mice (P < 0.01) as compared to control mice (Fig. 5). For
astrocytes, the (sex 9 drug) interaction term, P = 0.052, did not quite
reach conventional levels for statistical significance, nor was there
evidence for significant sex specificity in the microglial count (P = 0.4;
Fig. 5). Similarly, we observed a significant effect of NDGA (P = 0.013)
and sex (P = 0.023) on TNF-a expression in hypothalamic microglia,
without a significant interaction between NDGA treatment and sex
(Fig. 5A,B). Lastly, we saw no effect of NDGA treatment on astrocytes
and microglia activation in the hippocampus of 22-month-old mice
(Fig. 6).
Discussion
These data are the first to document the effect of lifespan-extending
drugs on neuro-inflammatory components, within brain regions that
are sensitive to aging. Modulation of lifespan by NDGA, ACA, and
17aE2 is sex specific, with males being more responsive to each of
these agents (Strong et al., 2008, 2016; Harrison et al., 2013). We
demonstrate here that hypothalamic inflammatory responses in 22-
month-old NDGA and 12-month-old ACA and 17aE2-treated mice are
reduced by these drugs in males but not in females. We saw no
consistent effects on inflammation in the hippocampus of the
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Fig. 1 Hypothalamic inflammation in
ACA- and 17aE2-treated mice as measured
by Iba-1+ microgial and TNF-a cells. Brain
sections of 12-month-old male and female
mice were analyzed for hypothalamic
microglia and TNF-a. (A) Representative
images showing immunostaining in the
MBH of control ACA- and 17aE2-treated
mice. Scale bars: 100 lm (far left); 20 lm
(right side panels), 3V, third ventricle. (B)
Numbers of cells immunoreactive for Iba-1
or TNF-a in the hypothalamic mediobasal
region (across the confocal microscopic
field of serial sections) from indicated male
and female mice; error bars show SEM for
N = 6 mice of each type. The p-value
shown as ‘Int’ represents the interaction
term in a two-factor ANOVA, testing
whether the drug effect differs between
male and female mice.
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drug-treated mice, supporting the idea that inhibition of the hypotha-
lamic inflammatory responses may play a particularly important role in
mouse lifespan extension (Zhang et al., 2013). Similarly, early-life
caloric restriction (CL between birth and 3 weeks of age; Sadagurski
et al., 2015a) and mutations that interfere with GH production or
response (Sadagurski et al., 2015b) also lead to reduced hypothalamic
inflammation in old mice. Our data now provide evidence that drugs
that extend lifespan might be effective in inhibiting hypothalamic
inflammatory processes in a sex-dependent manner.
It seems likely that the sex-specific effects of these drugs on both
inflammation and lifespan may reflect differences in hormonal patterns
between the sexes, although our current data do not distinguish
between effects of sex hormones in early life (i.e., prior to drug
exposure) and possible interactions with endocrine status during the
period of drug treatment. Neuron–glial plasticity is heavily influenced by
sex steroids and contributes to differential immune responses by sex
(Zagni et al., 2016). Sex steroids regulate the transcription of genes,
such as cytokines relevant to immune response and immune signaling
(Barna et al., 1996). In our study, we did not detect any effects of sex or
drug treatment on total cell numbers (DAPI staining), but we cannot
exclude the possibility that there may be have effects on neuronal cell
numbers. Future studies of the effects of ACA, 17aE2, and NDGA in
ovariectomized females and castrated males, or in mice lacking the
classical estrogen receptor, or in testosterone-treated females, would
help to clarify the basis for the effects of these drugs on male mice.
Information from such studies might suggest ideas about how the health
benefits of these three drugs might be extended to female mice and
about approaches to development of drugs that postpone aging both in
men and women.
In several of the models we have evaluated, drug treatment
diminishes inflammation in male mice to the level seen in untreated
female mice, but has little effect on the female animals. This observation
suggests the possibility of a threshold effect, the idea that inflammation
in females may already be at such a low level that drug treatment cannot
lead to further diminution. There is substantial evidence for sex-specific
differences in both microglia and astrocytes in the mouse brain
(McCarthy & Arnold, 2011; Pfau et al., 2016). Males have more
microglia in the CA1, CA3, and dentate gyrus (DG) of the hippocampus
and the amygdala early in postnatal development, whereas females have
more microglia with an activated morphology later in development, that
is, as juveniles and as young 3-month-old adults (Schwarz et al., 2012).
Our data show that male mice have higher levels of hypothalamic glia
than females, consistent with limited data in monkeys (Roberts et al.
2012), changes that may reflect early developmental effects rather than
effects of aging. Sex differences in glial number and morphology depend
on brain region and may well be modulated differently by drug and
endocrine status at later ages as well. We found no significant effect of
the anti-aging drugs on microglia numbers in the hippocampus at 12 or
22 months of age, although females had less microglia than males at the
older age. Consistent with this observation, we found no significant
effect of the drugs on astrocyte cell counts in hippocampus. A more
detailed analysis of separate subregions of the hippocampus would be
laborious and would require sections cut at orientations optimized for
this purpose, but might provide additional useful detail about regional
heterogeneity. Drugs that extend lifespan equally in males and females,
or which render females more responsive to the lifespan effects
mediated by ACA and 17aE2, will help provide additional insight into
this sexual dimorphism.
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Fig. 2 Microglia in the hippocampus of
ACA- and 17aE2-treated mice. (A)
Representative images of microglia
identified by immunofluorescent detection
of Iba-1 protein in coronal sections of CA1,
CA3, and dentate gyrus of the
hippocampus obtained from 12-month-old
male and female control, ACA-, and
17aE2-treated mice. Scale bars: 100 lm (B)
Quantification of Iba-1 in coronal sections
of left CA1, CA3, and dentate gyrus
considered together. Bars show mean and
SEM for N = 6 mice of each type. Acarbose
(ACA) led to a significant decline
(P = 0.011) in Iba-1+ cells, and there was
no significant interaction effect for both
treatments.
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In contrast to our data, a recent study by Hascup et al. (2016),
examining mRNA expression levels, found significant elevation in certain
NF-kB signaling molecules and glutamatergic markers in the hypotha-
lamus and different hippocampus areas in old GHR/ mice as
compared to controls. The methods used by Hascup provided relatively
little information about the specific cell type(s) expressing NF-kB
signaling molecules. In contrast, the conclusions of Zhang (Zhang et al.,
2013) and from our current and previous studies (Sadagurski et al.,
2015b) are based on immunostaining evaluation of inflammatory
markers. Such assessment provides an anatomical location of cells
within the area of interest suggesting the overall function to which those
cells contribute. As differential physiological properties have been
reported across hypothalamic areas as well as across septal and temporal
hippocampus, a combined approach of comprehensive molecular
mapping of inflammatory genes based on in situ hybridization (ISH)
data in long-lived mice can provide additional insight into discrete
cellular populations.
Glial cells are particularly sensitive to homeostatic imbalances.
Nutritional excess is a key activator of metabolic inflammation in the
hypothalamus, suggesting that interventions that can counteract
hypothalamic neuro-inflammation may protect against metabolic disor-
ders (Thaler & Schwartz, 2010). An inflammatory state in the hypotha-
lamus disrupts its ability to sense metabolic abnormalities, affecting
energy balance and glucose metabolism, leading to obesity and insulin
resistance (Thaler et al., 2012). It was recently demonstrated that there is
a sexually dimorphic response to chronic high-fat diet (HFD) exposure
(Morselli et al., 2014). Consistent with some of our findings in aged
mice, the work on HFD demonstrated that males, but not females, have
hypothalamic inflammation despite comparable weight gain following
HFD consumption (Morselli et al., 2014), further emphasizing the
physiological relevance of hypothalamic inflammation.
The sphingolipid system has emerged as a key player in modulation of
microglia phenotype in pathIogenic forms of neuroinflammation (Assi
et al., 2013). Sphingolipids accumulate in the liver and brain during
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Fig. 3 Hypothalamic astrogliosis in ACA-
and 17aE2-treated mice. (A) Representative
images of astrocytes identified by
immunofluorescent detection of GFAP
protein in coronal sections of hypothalamus
obtained from 12-month-old male and
female control, ACA-, and 17aE2-treated
mice. Scale bar: 100 lm. 3V, third
ventricle. (B) Quantification of GFAP
staining represents number of GFAP-
positive cells per field (error bars indicate
SEM; N = 6 mice per group) in the MBH
subregion. The significant interaction P-
value (P = 0.044) for ACA and (P = 0.039)
for 17aE2 indicates that both drugs have
different effects on GFAP+ cells in males vs.
females.
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aging, and long-term food restriction prevents aging-
associated sphingolipid turnover dysregulation (Babenko & Shakhova,
2014). Elevated levels of sphingolipids have previously been associated
with reduced insulin signaling and increased inflammation within the
CNS (Summers, 2006). Sphingolipids were significantly increased in the
hypothalamus of male animals fed with a HFD when compared to the
females (Morselli et al., 2014). The recent study by the Gladyshev group
showed that brains of old mice had higher concentrations of glyc-
erophospholipids and sphinogmyelins (Ma et al., 2015), key constituents
of cell membranes which play a role in neuroinflammation (Yadav &
Tiwari, 2014). Future metabolomics analysis from the hypothalamus per
se, from normal and drug-treated mice, would help to elucidate the
underlying biochemical mechanisms of sex-specific drug effects on
hypothalamic inflammation in aging.
In previously published work (Harrison et al., 2013), fasting insulin
levels in males were higher than in female controls, and ACA reduced
insulin levels in males to the level of control females. The male-specific
decline in fasting insulin level in ACA-treated mice hints that the altered
pattern of glucose spikes produced by ACA may lead to improved insulin
sensitivity in males, with less effect in females, and that this protection
against insulin resistance might in turn contribute to the sexual
dimorphism in longevity effect (Harrison et al., 2013) and in the age-
associated hypothalamic inflammation demonstrated in this study. It has
been reported that reduction in postprandial glucose peak levels by ACA
in patients with type 2 diabetes reduces postprandial activation of the
NF-jB pathway in blood cells (Rudofsky et al., 2004). NDGA lowers
blood glucose, ameliorates hypertriglyceridemia in male rats (female rats
were not tested; Zhang et al., 2015), and interferes with TNF-induced
NF-jB-mediated transactivation in 293 cells (van Puijenbroek et al.,
1999). The activity of ACA, NDGA, and 17aE2 as anti-inflammatory
agents opens new avenues for mechanistic testing and will prove to be
valuable for studying differences between male and female mice for
control of aging and late-life neurological diseases. It would be of
interest to learn whether ACA, NGDA, or 17aE2 modulates additional
pathways thought to be relevant to aging and lifespan, such as those
linked to ATF4, mTOR, autophagy, adipokine production, proteasome
function, and others, and do so in a sex-specific way.
Methods
Animals
Procedures involved in this study were approved by the University of
Michigan Committee on the Use and Care of Animals (UCUCA). UM-
HET3 mice were produced as previously described in detail (Miller et al.,
2007). For breeding cages, we used Purina 5008 mouse chow. For
weanlings prior to 4 months of age, we used Purina 5LG6. Animals were
maintained under temperature- and light-controlled conditions (20–
23 °C, 12-h light–dark cycle).
Experimental diets
17aE2 was purchased from Steraloids Inc. (Newport, RI, USA) and mixed
at a dose of 14.4 mg kg1 diet (14.4 ppm). Mice were fed the 17aE2
diet continuously from 4 months of age. NDGA was purchased from
Cayman Chemicals (Ann Arbor, MI, USA) and mixed at a concentration
of 2500 ppm and fed to mice beginning at 4 months of age. ACA was
purchased from Spectrum Chemical Mfg. Corp., Gardena, CA, USA. It
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Fig. 4 Astrocytes in the hippocampus of
ACA- and 17aE2-treated mice. (A)
Representative images of astrocytes
identified by immunofluorescent detection
of GFAP protein in coronal sections of CA1,
CA3, and dentate gyrus of the
hippocampus obtained from 12-month-old
male and female control, ACA-, and
17aE2-treated mice. Scale bars: 100 lm (B)
Quantification of GFAP staining represents
number of GFAP-positive cells in coronal
sections of left CA1, CA3, and dentate
gyrus considered together. Bars show mean
and SEM for N = 6 mice of each type.
There was no significant interaction effect
for GFAP with either drug. GFAP+ cells were
significantly higher in male mice regardless
of drug treatment.
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was mixed at a concentration of 1000 mg of ACA per kilogram of diet
(1000 ppm); mice were fed continuously from 4 months of age. For CR
feeding: starting at 4 months of age, CR mice were given 80% of the
amount of food consumed by age-matched ad lib control mice for
2 weeks. After that and continuing until euthanasia at 12 months of
age, the CR mice were given 60% of diet consumed by ad lib control
mice, as previously described (Miller et al., 2014).
Perfusion and immunolabeling
Mice were anesthetized (IP) with Avertin and transcardially perfused with
phosphate-buffered saline (PBS; pH 7.5) followed by 4%
paraformaldehyde (PFA). Brains were postfixed, dehydrated, and then
sectioned coronally (30 lm) using a sliding microtome, followed by
immunohistochemical or immunofluorescent analysis as previously
described (Sadagurski et al., 2015b). Brains from 22-month-old control
and NDGA-treated mice were only postfixed with 4% PFA. For
immunohistochemistry, free-floating brain sections were pretreated by
sequential incubations in 0.3% H2O2/1% NaOH, 0.3% glycine, 0.03%
SDS, followed by blocking in normal donkey serum (NDS). Sections were
incubated with rabbit anti-GFAP (1:1000; Millipore, Temecula, CA, USA),
mouse anti-TNF-a (1:500; Abcam, Cambridge, MA, USA) or rabbit anti-
Iba-1 (1:1000; Wako, Richmond, VA, USA) as primary antibodies
followed by AlexaFluor-conjugated secondary antibodies (Invitrogen,
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Fig. 5 NDGA diminishes hypothalamic
inflammation in hypothalamus. Brain
sections of 22-month-old male and female
mice were analyzed for hypothalamic
microglia, TNF-a, and astrocytes. (A)
Representative images showing Iba-1 and
TNF-a immunostaining merged with DAPI
(blue) in the hypothalamic mediobasal
region (MBH) of control and NDGA-treated
mice. Scale bars: 100 lm (far left); 20 lm
(right side panels), 3V, third ventricle. (B)
Numbers of cells immunoreactive for Iba-1
or TNF-a in the MBH (across the confocal
microscopic field of serial sections) from
indicated male and female mice. (C)
Representative images of astrocytes
identified by immunofluorescent detection
of GFAP protein in coronal sections of
hypothalamus. Scale bar: 100 lm. 3V, third
ventricle. (D) Quantification of GFAP
staining represents number of GFAP-
positive cells per field in the MBH
subregion. Bars show mean and SEM for 4
or 5 mice/group. Two-factor ANOVA
showed a significant effect of drug on
microglia numbers and TNF-a, but no
significant interaction (P = 0.14 for TNF-a
cells) between sex and drug treatment.
NDGA led to a significant reduction
(P = 0.01) in GFAP+ cells, and the
[sex 9 drug] interaction term just failed to
reach significance at P = 0.053.
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Carlsbad, CA, USA) as previously published (Sadagurski et al., 2012;
Zhang et al., 2013).
Sections were mounted onto Superfrost Plus slides (Fisher Scientific,
Hudson, NH, USA) and coverslips added with ProLong Antifade
mounting medium (Invitrogen). Microscopic images were obtained
using an Olympus FluoView 500 Laser Scanning Confocal Microscope
(Olympus, Center Valley, PA, USA) equipped with a 109, 209, and 409
objectives.
Quantification
For quantification of immunoreactive cells, images of matched brain
areas were taken from at least three sections containing the MBH of the
hypothalamus for each brain sections between bregma 0.82 mm to
2.4 mm (according to the Franklin mouse brain atlas). Serial brain
sections across the hypothalamus were made at 30 lm thickness, and
every five sections were represented by one section with staining and cell
counting. For quantification of the hippocampus sections, left side of
CA1, CA3, and dentate gyrus was considered together. All sections were
arranged from rostral to caudal to examine the distribution of labeled
glial cells. Iba-1 and GFAP-positive cells were counted using ImageJ
software with DAPI (nuclear stain). The average of the total number of
cells/field of view was used for statistical analysis as described previously
(Sadagurski et al., 2015b).
Statistical analysis
Data sets were analyzed using two-way analysis of variance (ANOVA)
followed by Tukey’s post hoc test. All data were presented as
mean  SEM. P < 0.05 was considered significant. IBM SPSS v.21 was
used for statistical analysis.
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